Support4sites.net

eldavojohn writes "Doctors Without Borders is reporting that four patents for tenofovir disoproxil fumarate, a key AIDS/HIV drug, have been revoked on grounds of prior art. This is potentially good news for India & Brazil who need this drug to be cheap; if the US action leads to the patent being rejected in these countries, competition could drastically lower prices. But the ruling bad news for Gilead Sciences. The company has vowed to appeal. We discussed this drug before."

Read more of this story at Slashdot.

How To Find a Mobile Games Publisher?

Resurrecting the Mighty Mammoth, Cheaply

Unix Dict/grep Solves Left-Side-of-Keyboard Puzzle

Kaminsky Bug Options Include "Do Nothing," Says IETF

Search For the Tomb of Copernicus Reaches an End

Apple DMCAs iPodHash Project

Network Neutrality — Without Regulation

Lessig, Zittrain, Barlow To Square Off Against RIAA

Study Recommends Online Gaming, Social Networking For Kids

CRTC Rules Bell Can Squeeze Downloads

MIT and NASA Designing Silent Aircraft

Spider Missing After Trip To Space Station

Studios Sue Oz ISP Over Allowing Piracy

Google Terminates Lively

IRS Looking at Google/Mozilla Relationship

New Xbox Experience Goes Live

NASA Exploring 8 New Space Expeditions

Towards a World Wide Grid?

Researchers Getting the Lead Out of Electronics

Adobe Releases C/C++ To Flash Compiler